https://wikem.org/w/index.php?action=history&feed=atom&title=Fondaparinux 2026-04-20T19:07:15Z Revision history for this page on the wiki MediaWiki 1.38.2 https://wikem.org/w/index.php?title=Fondaparinux&diff=300028&oldid=prev 2021-03-08T16:16:46Z

<p><span dir="auto"><span class="autocomment">Administration</span></span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:16, 8 March 2021</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Type: [[Anticoagulant]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Type: [[Anticoagulant]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms:</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms: <ins style="font-weight: bold; text-decoration: none;">Single-dose prefilled syringes of 2.5mg, 5mg, 7.5mg, and 10mg</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: Subcutaneous, IV</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: Subcutaneous, IV</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Common Trade Names: Arixtra</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Common Trade Names: Arixtra</div></td></tr> </table>

Elcatracho https://wikem.org/w/index.php?title=Fondaparinux&diff=229002&oldid=prev 2019-09-19T17:59:33Z

<p><span dir="auto"><span class="autocomment">Administration</span></span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:59, 19 September 2019</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Type: Anticoagulant</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*Type: <ins style="font-weight: bold; text-decoration: none;">[[</ins>Anticoagulant<ins style="font-weight: bold; text-decoration: none;">]]</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms:</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms:</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: Subcutaneous, IV</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: Subcutaneous, IV</div></td></tr> </table>

ClaireLewis https://wikem.org/w/index.php?title=Fondaparinux&diff=105412&oldid=prev 2016-10-09T22:42:15Z

<p>Created page with &quot;==Administration== *Type: Anticoagulant *Dosage Forms: *Routes of Administration: Subcutaneous, IV *Common Trade Names: Arixtra ==Adult Dosing== *STEMI, NSTEMI: 2.5mg daily *...&quot;</p> <p><b>New page</b></p><div>==Administration==<br /> *Type: Anticoagulant<br /> *Dosage Forms:<br /> *Routes of Administration: Subcutaneous, IV<br /> *Common Trade Names: Arixtra<br /> <br /> ==Adult Dosing==<br /> *STEMI, NSTEMI: 2.5mg daily<br /> *Acute DVT, PE: 5-10mg subq daily until warfarin therapeutic<br /> *VTE prophylaxis: 2.5mg subq daily<br /> <br /> ==Pediatric Dosing==<br /> ''Safety/efficacy not established''<br /> <br /> ==Special Populations==<br /> *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B<br /> *[[Lactation risk categories|Lactation risk]]: Infant risk cannot be ruled out<br /> *Renal dosing: contraindicated if CrCl &lt;30, use with caution if CrCl 30-50<br /> *Hepatic dosing: no adjustment<br /> <br /> ==Contraindications==<br /> *Allergy to class/drug<br /> *Active major bleeding<br /> *Bacterial endocarditis<br /> *Thrombocytopenia associated with antiplatelet antibody when tested with fondaparinux<br /> *Weight &lt;50kg<br /> *Severe renal impairment (CrCl &lt;30)<br /> <br /> ==Adverse Reactions==<br /> ===Serious===<br /> *Bleeding, anemia, thrombocytopenia<br /> *Epidural hematoma, spinal subdural hematoma<br /> ===Common===<br /> *Injection site reaction, rash<br /> *Fever<br /> <br /> ==Pharmacology==<br /> *Half-life: 17-21h<br /> *Metabolism: <br /> *Excretion: Renal<br /> <br /> ==Mechanism of Action==<br /> *Inhibits antithrombin III, neutralizing Factor Xa (similar to low molecular weight heparins)<br /> <br /> ==Comments==<br /> <br /> ==See Also==<br /> *[[Low Molecular Weight Heparin]]<br /> *[[Anticoagulant reversal for life-threatening bleeds]]<br /> <br /> ==References==<br /> &lt;references/&gt;<br /> [[Category:Pharmacology]]</div>

ClaireLewis